SOMERSET, N.J., Sept. 04, 2018 /PRNewswire-PRWeb/ -- Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and ...
PARSIPPANY, N.J.--(BUSINESS WIRE)--Pyros Pharmaceuticals, Inc. (Pyros or the Company), a leader in the development of enhanced specialty pharmaceuticals for rare diseases, announced today that ...
PARSIPPANY, N.J.--(BUSINESS WIRE)--Pyros Pharmaceuticals, Inc. (Pyros or the Company), a leader in the development of enhanced specialty pharmaceuticals for rare diseases, announced today that the U.S ...
Learn the correct pronunciation of the Vigabatrin, understand it's uses, recommended dosages, its indications, how to take, when to take, when not to take, side effects, special precautions, warnings ...
In new study results, researchers from the University of Alabama at Birmingham found that administering the preventive epilepsy treatment vigabatrin prior to seizure onset did not improve ...
Families often preferred to remain on treatment despite the risk of vision loss. For patients with focal seizures due to tuberous sclerosis, treatment with vigabatrin may be an effective option for ...
Credit: Pyros Pharmaceuticals. Vigafyde is supplied as a peppermint-flavored oral solution in a 150mL bottle. Vigafyde ™, a ready-to-use oral solution formulation of vigabatrin, is now available for ...
April 23, 2010 (San Francisco, California) — A double-blind, placebo-controlled phase 2 clinical trial of the anticonvulsant agent vigabatrin for cocaine dependence in the United States failed to show ...
Purpose: Vigabatrin (Sabril), a drug that blocks GABA transaminase, has been used in the treatment of epilepsy since 1989. There have been reports of irreversible constriction of the visual field in ...
H. Lundbeck A/S today announced that the US Food and Drug Administration (FDA) has granted two New Drug Application (NDA) approvals for Sabril® (vigabatrin) Tablets and Oral Solution. - First ...
Purpose To survey clinical visual function including quantitative manual perimetry results in a group of patients taking vigabatrin; to assess the severity of any field defects; to tabulate cumulative ...
Please provide your email address to receive an email when new articles are posted on . Vigabatrin did not significantly decrease cocaine use in patients, according to new data published in JAMA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results